Corporate
Description
  • Value proposition

    Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. We are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area. Around 200 million people around the world take a Teva medicine every day. They are served by one of the largest and most complex supply chains in the pharmaceutical industry. Along with our established presence in generics, we have significant innovative research and operations supporting our growing portfolio of specialty and biopharmaceutical products. Learn more at www.tevapharm.com.

    Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il

    Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here:
    http://www.tevapharm.com/contact_us/

    generic medicines, specialty medicines, CNS, active pharmaceutical ingredients, respiratory, biosimilars, biologics, pain care, migraine, and oncology

Entity interactions BETA
Entity TypeTweets Articles
Laboratorios Normon Laboratorios Normon
deeptech, Pharmaceutical Manufacturing
Other

4 May 2024


Stadt Ulm Stadt Ulm
Government Administration
Other

11 Apr 2024


Formycon AG Formycon AG
biotech, deeptech
Other

16 Apr 2024


L'Usine Nouvelle L'Usine Nouvelle
Newspaper Publishing
Other

22 Sep 2017

17 Apr 2024



The Kinetix Group-Powered by PetauriTM The Kinetix Group-Powered by PetauriTM
Hospitals and Health Care
Other

25 Mar 2024


mAbxience mAbxience
biotech, deeptech, Biotechnology Research
Other

1 Aug 2024


PM Society PM Society
healthtech, martech, Advertising Services
Other

21 Mar 2024


Abingworth Abingworth
Venture Capital and Private Equity Principals
Other

1 Apr 2024


Closed Loop Medicine Closed Loop Medicine
biotech, deeptech, healthtech, Biotechnology Research
Other

27 Mar 2024


Research and Markets Research and Markets
Market Research
Other

21 Feb 2024


Radars
Loading...